These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 11790238
1. A study validating changes in the multiple sclerosis functional composite. Hoogervorst EL, Kalkers NF, Uitdehaag BM, Polman CH. Arch Neurol; 2002 Jan; 59(1):113-6. PubMed ID: 11790238 [Abstract] [Full Text] [Related]
2. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies. Ozakbas S, Ormeci B, Idiman E. J Neurol Sci; 2005 May 15; 232(1-2):65-9. PubMed ID: 15850584 [Abstract] [Full Text] [Related]
12. How similar are commonly combined criteria for EDSS progression in multiple sclerosis? Kragt JJ, Nielsen IM, van der Linden FA, Uitdehaag BM, Polman CH. Mult Scler; 2006 Dec 15; 12(6):782-6. PubMed ID: 17263007 [Abstract] [Full Text] [Related]
13. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary]. Mezei Z, Bereczki D, Csiba L, Csépány T. Ideggyogy Sz; 2006 Nov 20; 59(11-12):442-7. PubMed ID: 17203882 [Abstract] [Full Text] [Related]
14. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS. Kragt JJ, Thompson AJ, Montalban X, Tintoré M, Río J, Polman CH, Uitdehaag BM. Neurology; 2008 Mar 25; 70(13 Pt 2):1084-91. PubMed ID: 18184917 [Abstract] [Full Text] [Related]
16. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite. Hobart J, Kalkers N, Barkhof F, Uitdehaag B, Polman C, Thompson A. Mult Scler; 2004 Feb 25; 10(1):41-6. PubMed ID: 14760951 [Abstract] [Full Text] [Related]
17. The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite. Costelloe L, O'Rourke K, McGuigan C, Walsh C, Tubridy N, Hutchinson M. Mult Scler; 2008 Mar 25; 14(2):255-8. PubMed ID: 17942522 [Abstract] [Full Text] [Related]
18. [Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data]. Pascual AM, Boscá I, Escutia M, Bernat A, Coret F, Casanova B. Neurologia; 2008 Mar 25; 23(2):73-7. PubMed ID: 17641984 [Abstract] [Full Text] [Related]
19. The multiple sclerosis functional composite: a new clinical outcome measure for multiple sderosis trials. Rudick RA, Cutter G, Reingold S. Mult Scler; 2002 Oct 25; 8(5):359-65. PubMed ID: 12356200 [Abstract] [Full Text] [Related]
20. Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale. Pascual AM, Boscá I, Coret F, Escutia M, Bernat A, Casanova B. Eur J Neurol; 2008 Mar 25; 15(3):284-8. PubMed ID: 18290849 [Abstract] [Full Text] [Related] Page: [Next] [New Search]